These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4124774)

  • 1. X-linked hypophosphataemic rickets: Inadequate therapeutic response to 1,25-dihydroxycholecalciferol.
    Glorieux FH; Holick MF; Scriver CR; DeLuca HF
    Lancet; 1973 Aug; 2(7824):287-9. PubMed ID: 4124774
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenesis of hereditary vitamin-D-dependent rickets. An inborn error of vitamin D metabolism involving defective conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D.
    Fraser D; Kooh SW; Kind HP; Holick MF; Tanaka Y; DeLuca HF
    N Engl J Med; 1973 Oct; 289(16):817-22. PubMed ID: 4357855
    [No Abstract]   [Full Text] [Related]  

  • 3. Actions of 1,25-dihydroxycholecalciferol in patients with hypophosphatemic, vitamin-D-resistant rickets.
    Brickman AS; Coburn JW; Kurokawa K; Bethune JE; Harrison HE; Norman AW
    N Engl J Med; 1973 Sep; 289(10):495-8. PubMed ID: 4353218
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemia.
    Glorieux FH; Scriver CR; Reade TM; Goldman H; Roseborough A
    N Engl J Med; 1972 Sep; 287(10):481-7. PubMed ID: 4340235
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of 1,25-dihydroxycholecalciferol on renal tubular reabsorption of phosphate, intestinal absorption of calcium and bone histology in hypophosphataemic renal tubular rickets.
    Russell RG; Smith R; Preston C; Walton RJ; Woods CG; Henderson RG; Norman AW
    Clin Sci Mol Med; 1975 Mar; 48(3):177-86. PubMed ID: 163719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment with 1,25-dihydroxycholecalciferol in children with different types of resistant rickets].
    Eggers M; Beas F
    Rev Chil Pediatr; 1982; 53(2):95-101. PubMed ID: 6294757
    [No Abstract]   [Full Text] [Related]  

  • 7. Familial forms of vitamin D-resistant rickets revisited. X-linked hypophosphatemia and autosomal recessive vitamin D dependency.
    Fraser D; Scriver CR
    Am J Clin Nutr; 1976 Nov; 29(11):1315-29. PubMed ID: 187056
    [No Abstract]   [Full Text] [Related]  

  • 8. New developments in pharmacology of vitamin D.
    Med Lett Drugs Ther; 1974 Feb; 16(3):15-6. PubMed ID: 4358446
    [No Abstract]   [Full Text] [Related]  

  • 9. Familial hypophosphatemia: the dilemma of treatment.
    Scriver CR
    N Engl J Med; 1973 Sep; 289(10):531-2. PubMed ID: 4353219
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of 25-hydroxycholecalciferol on urinary electrolyte excretion in hypophosphataemic rickets.
    Puschett JB; Genel M; Rastegar A; Anast C; DeLuca HF
    Lancet; 1974 Oct; 2(7886):920-2. PubMed ID: 4138190
    [No Abstract]   [Full Text] [Related]  

  • 11. Inadequate bone response to phosphate and vitamin D in familial hypophosphatemic rickets (FHR).
    Glorieux FH; Bordier PJ; Marie P; Delvin EE; Travers R
    Adv Exp Med Biol; 1978; 103():227-32. PubMed ID: 213951
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of hypophosphataemic vitamin D-resistant rickets with massive doses of 1 alpha-hydroxy-vitamin D3 during childhood.
    Seino Y; Shimotsuji T; Ishii T; Ishida M; Ikehara C; Yamaoka K; Yabuuchi H; Dokoh S
    Arch Dis Child; 1980 Jan; 55(1):49-53. PubMed ID: 6246841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vitamin d: recent acquisitions].
    Balsan S
    Arch Fr Pediatr; 1974 Nov; 31(9):837-41. PubMed ID: 4376939
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal hypophosphataemic bone disease responds to 1,25-(OH)2D3.
    Scriver CR; Reade T; Halal F; Costa T; Cole DE
    Arch Dis Child; 1981 Mar; 56(3):203-7. PubMed ID: 7212758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D-resistant rickets.
    Balsan S
    Compr Ther; 1977 Oct; 3(10):54-8. PubMed ID: 198177
    [No Abstract]   [Full Text] [Related]  

  • 17. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets.
    Glorieux FH; Marie PJ; Pettifor JM; Delvin EE
    N Engl J Med; 1980 Oct; 303(18):1023-31. PubMed ID: 6252463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of hyperparathyroidism in children with X-linked hypophosphatemia under treatment with vitamin D and phsophate.
    Krohn HP; Offermann G; Brandis M; Brodehl J; Hanke K; Offner G
    Adv Exp Med Biol; 1977; 81():345-51. PubMed ID: 899930
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypophosphatemic vitamin D refractory rickets and osteomalacia.
    Parfitt AM
    Orthop Clin North Am; 1972 Nov; 3(3):653-80. PubMed ID: 4344934
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of 25-hydroxycholecalciferol in patients with familial hypophosphatemia and vitamin-D-resistant rickets.
    Earp HS; Ney RL; Gitelman HJ; Richman R; DeLuca HF
    N Engl J Med; 1970 Sep; 283(12):627-30. PubMed ID: 4317911
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.